Norlase

Norlase is a pioneering global ophthalmic medical device company specializing in advanced laser solutions for retina and glaucoma treatments. Our team comprises esteemed experts in ophthalmology, laser technology, medical device development, and customer care.

At Norlase, our vision is clear: to revolutionize ophthalmic care worldwide. We strive to empower ophthalmologists, enhance patient care, and optimize practice efficiency. Collaborating with a network of industry leaders and ophthalmologists, we aim to create transformative changes in the field.

Our co-founder, Oliver, leads Norlase with a commitment to quality, transparency, and innovation. Greg Fava brings over 25 years of ophthalmic laser experience, Andrew Berkowitz contributes over 30 years of ophthalmic sales expertise, and Taoufiq Jellal brings extensive experience in market growth. High-tech entrepreneur Peter M. W. Skovgaard and laser scientist Danny Noordegraaf further drive our technological breakthroughs.

Jan, with his background in quality management, ensures Norlase adheres to the highest standards, including ISO 13485 and QSR 820. Jan's leadership led to EU MDR certification and FDA 510(K) clearance for our green laser systems.